BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15095269)

  • 41. Gastrointestinal stromal tumors: a 19 year experience.
    Rabin I; Chikman B; Lavy R; Sandbank J; Maklakovsky M; Gold-Deutch R; Halpren Z; Wassermann I; Halevy A
    Isr Med Assoc J; 2009 Feb; 11(2):98-102. PubMed ID: 19432038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chromosomal aberrations detected by comparative genomic hybridization predict outcome in patients with colorectal carcinoma.
    Liu XP; Kawauchi S; Oga A; Sato T; Ikemoto K; Ikeda E; Sasaki K
    Oncol Rep; 2007 Jan; 17(1):261-7. PubMed ID: 17143507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Altered expression of cell cycle regulatory proteins in gastrointestinal stromal tumors: markers with potential prognostic implications.
    Sabah M; Cummins R; Leader M; Kay E
    Hum Pathol; 2006 Jun; 37(6):648-55. PubMed ID: 16733203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significant involvement of chromosome 13q deletions in progression of larynx cancer, detected by comparative genomic hybridization.
    Schlade-Bartusiak K; Stembalska A; Ramsey D
    J Appl Genet; 2005; 46(4):407-13. PubMed ID: 16278516
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA.
    Gazvoda B; Juvan R; Zupanic-Pajnic I; Repse S; Ferlan-Marolt K; Balazic J; Komel R
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1082-9. PubMed ID: 17998833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.
    Haller F; Löbke C; Ruschhaupt M; Schulten HJ; Schwager S; Gunawan B; Armbrust T; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Oct; 216(2):225-35. PubMed ID: 18729075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic factors in malignant gastrointestinal stromal tumors.
    Muro-Cacho CA; Cantor AB; Morgan M
    Ann Clin Lab Sci; 2000 Jul; 30(3):239-47. PubMed ID: 10945563
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical treatment of gastric gastrointestinal stromal tumors: analysis of 92 operated patients.
    Lai IR; Chen CN; Lin MT; Lee PH
    Dig Surg; 2008; 25(3):208-12. PubMed ID: 18577866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNA copy number aberrations in intestinal-type gastric cancer revealed by array-based comparative genomic hybridization.
    Vauhkonen H; Vauhkonen M; Sajantila A; Sipponen P; Knuutila S
    Cancer Genet Cytogenet; 2006 Jun; 167(2):150-4. PubMed ID: 16737915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas.
    Meza-Zepeda LA; Kresse SH; Barragan-Polania AH; Bjerkehagen B; Ohnstad HO; Namløs HM; Wang J; Kristiansen BE; Myklebost O
    Cancer Res; 2006 Sep; 66(18):8984-93. PubMed ID: 16982739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of p53 gene mutations and protein overexpression in localized gastrointestinal stromal tumours.
    Ryu MH; Kang YK; Jang SJ; Kim TW; Lee H; Kim JS; Park YH; Lee SS; Ryoo BY; Chang HM; Lee JL; Yook JH; Kim BS; Lee JS
    Histopathology; 2007 Sep; 51(3):379-89. PubMed ID: 17727479
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization.
    Takeno SS; Leal MF; Lisboa LC; Lipay MV; Khayat AS; Assumpção PP; Burbano RR; Smith Mde A
    Cancer Genet Cytogenet; 2009 Apr; 190(1):1-7. PubMed ID: 19264226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor.
    Rutkowski P; Nowecki ZI; Michej W; Debiec-Rychter M; Woźniak A; Limon J; Siedlecki J; Grzesiakowska U; Kakol M; Osuch C; Polkowski M; Głuszek S; Zurawski Z; Ruka W
    Ann Surg Oncol; 2007 Jul; 14(7):2018-27. PubMed ID: 17473953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative genomic hybridization reveals genetic progression of oral squamous cell carcinoma from dysplasia via two different tumourigenic pathways.
    Noutomi Y; Oga A; Uchida K; Okafuji M; Ita M; Kawauchi S; Furuya T; Ueyama Y; Sasaki K
    J Pathol; 2006 Sep; 210(1):67-74. PubMed ID: 16767698
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors.
    Assämäki R; Sarlomo-Rikala M; Lopez-Guerrero JA; Lasota J; Andersson LC; Llombart-Bosch A; Miettinen M; Knuutila S
    Genes Chromosomes Cancer; 2007 Jun; 46(6):564-76. PubMed ID: 17330260
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
    Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
    Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Surgical outcomes and immunohistochemical features for gastrointestinal stromal tumors (GISTS) of the stomach: with special reference to prognostic factors.
    Park SS; Ryu JS; Oh SY; Kim WB; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
    Hepatogastroenterology; 2007; 54(77):1454-7. PubMed ID: 17708275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
    Miettinen M; Wang ZF; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.